Exor (ENXTAM:EXO) has quietly slipped over the past year, with shares down around 23% even as its underlying holdings like Ferrari and Stellantis keep executing. That gap is exactly what value focused ...

Exor’s long-term investment results have been undeniably strong, a fact that the market seems unwilling to recognize. The group’s portfolio has a bias toward cyclicals, but steps are being taken to ...

The Tender Offer will be carried out as part of the €1 billion share buyback program announced by Exor in February 2025. Exor's Board of Directors believes that the current value of Exor provides an ...

Philips resolved the Respironics litigation, settling for $1.1 billion. And Exor decided to boost its stake in the company. Supportive shareholders' remuneration is linked to Exor's portfolio results, ...

Exor, the holding company of Italy's Agnelli family, will have about 9 billion euros ($10.2 billion) available for investments next year once it completes the sale of reinsurer PartnerRe, Chief ...